Researchers in Groningen developed MNVista, an open-source Bayesian tool that detects multi-nucleotide variants in sequencing data to identify circulating tumor DNA from B-cell lymphoma at levels as low as 25 parts per million.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.